Or search by therapeutic classification
| Pr | upadacitinib 15mg RINVOQ |
| oral tablet (extended-release) images | |
| JANUS-ASSOCIATED KINASE (JAK) INHIBITORS (L04AF) | |
| For more drugs in this class, see also | |
| BC Pharmacare: LIMITED COVERAGE DRUG SA for dermatitis SA for Crohns | |
| Unit Price: 54.27 Packaging: Monograph: UpToDate or Epocrates |
| Pr | upadacitinib 30mg RINVOQ |
| oral tablet (extended-release) images | |
| JANUS-ASSOCIATED KINASE (JAK) INHIBITORS (L04AF) | |
| For more drugs in this class, see also | |
| BC Pharmacare: LIMITED COVERAGE DRUG SA for dermatitis SA for Crohns | |
| Unit Price: 80.81 Packaging: Monograph: UpToDate or Epocrates |
| Pr | upadacitinib 45mg RINVOQ |
| oral tablet (extended-release) images | |
| JANUS-ASSOCIATED KINASE (JAK) INHIBITORS (L04AF) | |
| For more drugs in this class, see also | |
| BC Pharmacare: LIMITED COVERAGE DRUG SA for dermatitis SA for Crohns | |
| Unit Price: 106.90 Packaging: Monograph: UpToDate or Epocrates |
Notes: If BC Pharmacare information is n/a, the drug is probably not covered by any plan. LCA partial benefit means that there is a generic available as a full benefit. Non-reference drug means that there is an alternative drug in the same class available as a full benefit. Prices are per unit (tablet, g, ml, etc) and are the maximum wholesale that Pharmacare will pay. Prices are not available for all drugs. Monograph and other information is available at the websites listed, all of which require log-in. Epocrates is free. UpToDate requires subscription but is free to BC Divisions of Family Practice members. If you log into UpToDate BEFORE using the Medi-Mouse drug search, the link will take you directly to the drug information.
* This feature only works if you search by generic name.
Using Health Canada Drug Database and BC Pharmanet Drug Master File updated on 14Sep2025.